Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory Cell and Molecular Biology|November 29, 2023
GOLM1 Promotes Pulmonary Fibrosis through Upregulation of NEAT1Yani Wang, Danjing Hu, Linyan Wan, et al.
Cardiovascular Research|April 6, 2026
Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failureYinlong Zhao, Xiaolu Bao, Weiyao Xiong, et al.
Signal Transduction and Targeted Therapy|November 5, 2023
SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancerXiayao Diao, Chao Guo, Hanhao Zheng, et al.
Translational Lung Cancer Research|December 13, 2024
Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional studyZhicheng Huang, Ming Zhao, Bowen Li, et al.
EMBO Reports|November 3, 2025
Early-stage lung adenocarcinoma affects DNA methylation and gene expression in adjacent tissuesYifan Wu, Yadong Wang, Yao Tang, et al.
Targeted Oncology|March 22, 2019
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with CrizotinibYudong Su, Xiang Long, Yang Song, et al.
Translational Lung Cancer Research|June 15, 2026
Utilizing clinical features, genetic mutations, and a 14-gene molecular assay for optimizing the management of multiple primary lung cancerBowen Li, Zhibo Zheng, Zhina Wang, et al.
NPJ Precision Oncology|October 9, 2024
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathwayHaochen Li, Zhicheng Huang, Chao Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2022
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA TrialMargarita Majem, Jonathan W Goldman, Thomas John, et al.
Translational Lung Cancer Research|April 23, 2021
HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinomaZiqi Jia, Jiahua Xing, Ji Li, et al.
Pageof 23